Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
Superinvestors holding FUSN, Q1 2024
1 superinvestor reports holding Fusion Pharmaceuticals Inc. on Form 13F, worth $8.52M in total. Weight is Fusion Pharmaceuticals Inc.'s share of each 13F portfolio; actions compare shares with Q4 2023.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Duquesne Family OfficeStanley Druckenmiller | 0.2% | 399,748 | $8.52M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of FUSN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2024
1 superinvestor holding at quarter end